Research Article
The Evaluation of Red Cell Distribution Width in Chronic Hemodialysis Patients
Table 1
The clinical and demographic characteristics of the patients.
| Parameter | Group 1 () | Group 2 () | Group 3 () | Group 4 () | |
| Age (years) | | | | | | Gender (female/male) () | 39/53 | 37/44 | 30/44 | 21/28 | | HD duration (months) | | | | | | Presence of DM (yes/no) (n) | 37/55 | 29/52 | 23/51 | 19/30 | | Presence of CAD (yes/no) (n) | 17/75 | 16/65 | 12/62 | 13/36 | | Presence of Rtx history (yes/no) () | 4/88 | 2/79 | 3/71 | 1/48 | | Predialysis systolic BP (mm Hg) | | | | | | Predialysis diastolic BP (mm Hg) | | | | | | Iron/EPO treatment (present/absent) | 0/296 | 0/81 | 0/74 | 0/49 | | Anti-P treatment (present/absent) (n) | 55/37 | 38/43 | 21/53 | 19/30 | | Interdialytic weight gain (kg) | | | | | | Cardiothoracic index (%) | | | | | |
|
|
Differences assessed by ANOVA* (for parametrical data) or Kruskal-Wallis test† (for nonparametric data) for numerical variables and by Chi-square test‡ for categorical variables. Statistically significance: . HD: hemodialysis, DM: diabetes mellitus, CAD: coronary artery disease, Rtx: renal transplantation, BP: blood pressure, EPO: erythropoietin, and P: phosphate.
|